First, CD19 is a B-cell marker. CD5 is typically found in T-cells and some B-cell malignancies. CD23 is usually positive in chronic lymphocytic leukemia (CLL), but here it's negative. That makes me think of other B-cell disorders. CD5 positivity in B-cells suggests a B-lymphoproliferative disorder.
CD5+ B-cell cancers include hairy cell leukemia (HCL) and mantle cell lymphoma (MCL). HCL usually has CD25+ and CD11c+, and CD23 is often negative. But HCL also has a more distinct morphology with hair-like projections. Mantle cell lymphoma is CD5+ and CD23-, but it's more aggressive and often presents with lymphadenopathy. However, MCL is usually associated with a higher proportion of blasts and may have other markers like cyclin D1.
Then there's chronic lymphocytic leukemia (CLL), which is CD5+ and CD23+. But in this case, CD23 is negative, so that's out. Another possibility is lymphoplasmacytic lymphoma, but that's CD5- and usually associated with IgM monoclonal gammopathy.
So, CD5+ CD23- B-cell lymphoproliferative disorders. Hairy cell leukemia is a strong candidate here. The presence of monoclonal kappa light chains is common in B-cell malignancies. The massive splenomegaly and high WBC count are consistent with HCL. Also, HCL typically presents with pancytopenia due to marrow infiltration, which might be present here.
Wait, but the question mentions monoclonal B-cells. HCL is a B-cell lymphoproliferative disorder, so that fits. The key points are CD5+ CD23- and the clinical presentation. So the correct answer should be Hairy Cell Leukemia.
**Core Concept** This question tests the recognition of B-cell lymphoproliferative disorders based on immunophenotyping. CD5+ CD23- B-cell monoclonality with splenomegaly and lymphadenopathy is characteristic of **hairy cell leukemia (HCL)**, a unique B-cell malignancy.
**Why the Correct Answer is Right** Hairy cell leukemia is defined by CD19+, CD5+, CD23- B-cells with monoclonal light chains (kappa/lambda). It presents with massive splenomegaly, pancytopenia, and lymphocytosis. The CD23 negativity distinguishes it from **CLL (CD23+)**, while CD5 positivity aligns with B-cell origin. The monoclonal kappa positivity confirms clonality, essential for malignancy diagnosis.
**Why Each Wrong Option is Incorrect**
**Option A:** *Chronic lymphocytic leukemia (CLL)* is CD5+ and **CD23+**, which contradicts the CD23-negative result here
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.